CRINETICS PHARMACEUTICALS IN (CRNX) Stock Cash Flow
NASDAQ:CRNX • US22663K1079
Current stock price
37.49 USD
+0.98 (+2.68%)
At close:
37.49 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -465.32M | -298.41M | -214.53M | -163.92M | -107.64M | |||
| Depreciation Amortization | 3.89M | 2.79M | 1.10M | 980.00K | 920.00K | |||
| Change In Working Capital | 4.84M | 7.41M | 5.75M | 18.61M | 1.10M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 78.66M | 58.02M | 39.08M | 29.12M | 17.04M | |||
| OPERATING CASH FLOW | -377.92M | -230.19M | -168.60M | -115.21M | -88.59M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.76M | -3.84M | -4.69M | -1.66M | -440.00K | |||
| Other Investing Activity | 179.67M | -570.97M | -195.72M | -172.32M | -56.05M | |||
| INVESTING CASH FLOW | 173.91M | -574.82M | -200.41M | -173.98M | -56.48M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 40.61M | 1.03B | 391.78M | 121.96M | 252.68M | |||
| Other Financing Activity | 0.00 | -14.98M | -541.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 40.61M | 1.01B | 391.24M | 121.96M | 252.68M | |||
| Exchange Rate Effect | -106.00K | 0.00 | 0.00 | N/A | N/A | |||
| CHANGE IN CASH | -163.51M | 209.65M | 22.22M | -167.23M | 107.61M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -377.92M | -230.19M | -168.60M | -115.21M | -88.59M | |||
| Capital Expenditure | -5.76M | -3.84M | -4.69M | -1.66M | -440.00K | |||
| FREE CASH FLOW | -383.68M | -234.04M | -173.29M | -116.87M | -89.03M | |||
All data in USD